• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Misdiagnosis and Treatment of Paget-Schroeter Syndrome

  • Wed, 8/4/10 - 2:49pm
  • 0 Comments
  • 2276 reads
Start Page: 
178
End Page: 
178
Author(s): 

Ross Milner, MD


VASCULAR DISEASE MANAGEMENT 2010;7:E178

_________________________________________________



Upper-limb deep venous thrombosis (DVT), Paget-Schroetter syndrome, or effort thrombosis, is a problem that is commonly misdiagnosed and improperly treated. The authors present a straightforward case of upper-limb DVT that appropriately highlights the diagnosis and management of this problem, while raising an important management issue.

As mentioned by the authors, effort thrombosis usually occurs in younger patients. It is usually accompanied by a history of frequent, repetitive upper-extremity movements. Ultrasound can usually make the diagnosis. This allows for the decision to treat with a venogram and thrombolysis. Mechanical thrombectomy can also be utilized to achieve a successful result. After successful thrombolysis, a decision can be made for the timing of a first rib resection. Some physicians recommend removing the first rib during the same hospitalization. Others recommend waiting 4–6 weeks before the first rib surgery. I think many people are transitioning to immediate resection, and this is my preference as well.

I think the authors have described the identification of this problem well, and I wholeheartedly agree with the thrombolytic therapy. However, I disagree with not removing the first rib. I believe successful thrombolysis will minimize the risk of developing post-phlebitic syndrome. I am concerned that the risk of life-long anticoagulation in a young patient poses a higher risk than the surgery, thus, I would have counseled the patient differently.

_________________________________________________



From the Division of Vascular Surgery and Endovascular Therapy, Loyola University Medical Center, Maywood, Illinois.

The author reports no conflict of interest regarding the content herein.

Address for correspondence: Ross Milner, MD, Associate Professor of Surgery, Chief, Division of Vascular Surgery and Endovascular Therapy, Loyola University Medical Center, Maywood, Illinois. E-mail: rmilner@lumc.edu

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications